Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

HESTER BIOSCIENCES LTD.

NSE : HESTERBIOBSE : 524669ISIN CODE : INE782E01017Industry : Pharmaceuticals & DrugsHouse : Private

BSE1765.00-22.75 (-1.27 %)

PREV CLOSE ( ) 1787.75

OPEN PRICE ( ) 1798.95

BID PRICE (QTY) 1760.90 (2)

OFFER PRICE (QTY) 1765.00 (1)

VOLUME 78

TODAY'S LOW / HIGH ( )1759.00 1798.95

52 WK LOW / HIGH ( )1292.9 1928.45

NSE1760.00-19.8 (-1.11 %)

PREV CLOSE( ) 1779.80

OPEN PRICE ( ) 1784.55

BID PRICE (QTY) 1760.10 (1)

OFFER PRICE (QTY) 1763.00 (10)

VOLUME 738

TODAY'S LOW / HIGH( ) 1760.00 1785.40

52 WK LOW / HIGH ( )1292.85 1939.95

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1987

Management Info

Bhupendra V Gandhi - Chairman Rajiv Gandhi - Managing Director

Registered Office

Address Pushpak’ 1st Floor,Panchvati Circle,Motila Hirabhai Road,
Ahmedabad,
Gujarat-380006

Phone 079 – 26445106

Email mail@hester.in

Website www.hester.in

Registrars Details

Link Intime India Pvt Ltd.

506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad

Listing : BSE, NSE

NEWS

16May Hester Biosciences informs about compl
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure R..

08May Hester Biosciences informs about earni
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

09Apr Hester Biosciences informs about revis
Pursuant to Regulation 40(9) of SEBI (Listing Obligations and Disclosure..

04Apr Hester Biosciences informs about compl
Hester Biosciences has informed that it submitted the compliance Certifi..

02Feb Hester Biosciences informs about outco
Hester Biosciences has informed that Board of Directors, in their Meetin..

Financials

Rs. in Millions

	QTR Mar 24	ANNUAL 24
Net Profit	74.3100000000001	271.59
Gross Profit	102.25	367.32
Operating Profit	136.18	516.03
Net Sales	728.72	2851.55

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE) 8910.00 (3.96%)	M.Cap ( in Cr)20289.98
Astrazeneca Pharma I (BSE) 5775.80 (2.42%)	M.Cap ( in Cr)14220.00
Pfizer (BSE) 4391.50 (1.28%)	M.Cap ( in Cr)19966.37
Zydus Lifesciences (BSE) 1031.85 (2.30%)	M.Cap ( in Cr)103118.86
AMI Organics (BSE) 1250.25 (1.63%)	M.Cap ( in Cr)4563.42

Shareholding Pattern

	PROMOTERS	53.73%
	NON-INSTITUTION	45.84%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Motilal Oswal S&P B...	0.05

Risk Disclosures on Derivatives

Smart Quotes

HESTER BIOSCIENCES LTD.